194
Participants
Start Date
March 18, 2021
Primary Completion Date
April 20, 2022
Study Completion Date
May 19, 2022
BGE-175
Drug
Placebo
Placebo
Jadestone Clinical Research, LLC, Silver Spring
University of Maryland Medical System, Baltimore
University of Florida - Health, Jacksonville, Jacksonville
Baptist Health, Lexington, Lexington
North Colorado Medical Center, Greeley
Banner Health, Mesa
Long Beach Medical Center, Long Beach
Velocity Clinical Research, Chula Vista, Chula Vista
Sharp Memorial Hospital, San Diego
UCI Center for Clinical Research, Orange
Stamford Hospital, Stamford
Clinica Privada Independencia, Ciudad Autonoma de Buenos Aires
Sanatorio De La Trinidad Mitre, Buenos Aires
Clinica Adventista Belgrano (CAB), Buenos Aires
Hospital Universitário Cassiano Antônio de Moraes, Vitória
Hospital Felicio Rocho (HFR), Belo Horizonte
Centro de Pesquisa Hospital Ana Nery Santa Cruz do Sul, Santa Cruz do Sul
Hospital Ernesto Dornelles, Porto Alegre
Clínica Supera Oncologia, Chapecó
Unidade de Pesquisa Clinica da Fundação Pio XII - Hospital de Amor de Barretos, Barretos
Hospital das Clínicas da Faculdade de Medicina de Botucatu UNESP (HC-FMB/UNESP), Botucatu
Pontificia Universidade Catolica de Campinas (PUC-CAMP) - Hospital e Maternidade Celso Pierro (HMCP) - Centro de Pesquisa São Lucas, Campinas
Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José do Rio Preto
Conjunto Hospitalar de Mandaqui, São Paulo
Clinica de Alergia Martti Antila, Sorocaba
Instituto Nacional de Infectologia Evandro Chagas / Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro
Lead Sponsor
BioAge Labs, Inc.
INDUSTRY